Predicting cancer prognosis
Links shared publicly online about this topic.
- 1,792total visits
Predicting cancer prognosis
View full resource at physorg.com
Tags: Cancer, Skin Cancer, Melanoma
Most Recently Shared on August 27, 2009 at 6:14 pm By:
Study assesses link between antifolate medications, KRAS mutations and amplification
news-medical.net — “Testing patients with non-small cell lung cancer for both mutations and amplifications of the KRAS gene prior to therapy may help to predict response to treatment with antifolates, according to the updated results of a preclinical study presented at the AACR Annual Meeting 2012, held here March 31 - April 4.” View full resource at news-medical.net
Most Recently Shared on April 5, 2012 at 11:29 am By:
Lung Cancer News: Study assesses link between antifolate medications, KRAS mutations and amplification: Testing ... http://t.co/pTIigUcV
Study Says DNA’s Power to Predict Illness Is Limited - NYTimes.com
nytimes.com — “Personalized disease forecasts and therapies are not the wave of the future, research on twins suggests.” View full resource at nytimes.com
Most Recently Shared on April 2, 2012 at 8:30 pm By:
JohnsHopkinsMedicine Health News
Whole genome tests will not be substitutes for current disease prevention strategies. http://t.co/FiRwm3az #cancer #research
Susan G. Komen for the Cure | Research & Grants | Triple Negative Breast Cancer – what do we know and where are we headed?
ww5.komen.org — “Although breast cancer is often referred to as one disease, there are actually many different types of breast cancer. The differences can help guide treatment and provide information on prognosis. Cer” View full resource at ww5.komen.org
Most Recently Shared on March 27, 2012 at 2:00 pm By:
Komen Greater NYC Health Organization
What do we know about Triple Negative Breast Cancer? Treatment options are limited but are actively being researched. http://t.co/HBI82pnC
Science-Based Medicine » CAM as a Dumping Ground
sciencebasedmedicine.org — “I know a woman who is a survivor of colorectal cancer. At one point, doctors had given up hope and put her in hospice, but she failed to die as predicted and...” View full resource at sciencebasedmedicine.org
Most Recently Shared on March 27, 2012 at 7:09 am By:
David Gorski Physician, Doctor, Surgeon, and Oncologist
CAM as a Dumping Ground http://t.co/vnxGEkrj
Hereditary breast and ovarian cancer - JAAPA
jaapa.com — “Patients who test positive for the BRCA1/2 mutations that cause breast and ovarian cancers have options when it comes to surveillance and prevention.” View full resource at jaapa.com
Most Recently Shared on March 26, 2012 at 1:10 pm By:
How you can use #genomics to predict & influence hereditary #breastcancer and #ovariancancer http://t.co/oBgDhjC3
Medical News:Clinical Notes: Breast Density Predicts Cancer Return - in Oncology/Hematology, Breast Cancer from MedPage Today
medpagetoday.com — “Medical News:Clinical Notes: Breast Density Predicts Cancer Return - in Oncology/Hematology, Breast Cancer from MedPage Today” View full resource at medpagetoday.com
Most Recently Shared on March 25, 2012 at 7:08 pm By:
Clinical Notes: Breast Density Predicts Cancer Return http://t.co/kst7t60F
Medical News:Clinical Notes: Breast Density Predicts Cancer Return - in Oncology/Hematology, Breast Cancer from MedPage Today
medpagetoday.com — “Medical News:Clinical Notes: Breast Density Predicts Cancer Return - in Oncology/Hematology, Breast Cancer from MedPage Today” View full resource at medpagetoday.com
Most Recently Shared on March 25, 2012 at 6:35 pm By:
Thomas Loarie, Jr Health Advocate
@medpagetoday Clinical Notes: Breast Density Predicts Cancer Return http://t.co/nMqTJMjy #medical #Health
DNA marker predicts platinum drug response in breast, ovarian cancer - Dana-Farber Cancer Institute
dana-farber.org — “Dana-Farber and Brigham and Women’s researchers have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers might respond to platinum-based chemotherapies.” View full resource at dana-farber.org
Most Recently Shared on March 24, 2012 at 10:30 pm By:
Discovery of genetic marker predicting response to platinum drugs in triple-negative #breastcancer http://t.co/IFMrAlTO
Overweight and obese women at greater risk of breast cancer recurrence
eurekalert.org — “Women who are overweight or obese when they are diagnosed with breast cancer are at higher risk of cancer recurrence or related death than are leaner women, according to a new study. The finding held true even though the study mandated that chemotherapy dosage be adjusted for body weight, and adds further to the evidence that lifestyle factors can influence cancer prognosis, the American researchers say.” View full resource at eurekalert.org
Most Recently Shared on March 24, 2012 at 5:41 pm By:
Raymond DuBois Health Executive, Physician, Doctor, Internist, and Gastroenterologist
Overweight and obese women at greater risk of breast cancer recurrence: http://t.co/DnhvZfP5 via @AddThis
Identifying acute myeloid leukemia gene mutations may indicate risk, best treatment
labspaces.net — “An international group of researchers, including those from Moffitt Cancer Center in Tampa, Fla., have published a paper in the March 14 issue of the New England Journal of Medicine reviewing the results of a study that analyzed mutations in 18 genes of 398 patients who had acute myeloid leukemia (AML). They found that several mutated genes predicted improved outcomes when pat” View full resource at labspaces.net
Most Recently Shared on March 24, 2012 at 1:30 pm By:
Identifying acute myeloid leukemia gene mutations may indicate risk, best treatment - http://t.co/NvuNlhkt
Predicting Response To Platinum Chemotherapy Via Marker Of DNA Damage - QualityPoint Technologies
qualitypointtech.net — “Scientists have uncovered a marker of DNA damage that could predict who will respond to platinum-based chemotherapy drugs like cisplatin or carboplatin. These drugs are widely used for ovarian cancer, but as with most cancer drugs, it can be difficult to predict who will respond to therapy. A team of researchers from the Dana-Farber Cancer Institute found that this marker, telomeric allelic imbalance or tAI, could predict sensitivity to therapy in patients with triple-negative breast cancer...” View full resource at qualitypointtech.net
Most Recently Shared on March 24, 2012 at 11:00 am By:
Predicting Response To Platinum Chemotherapy Via Marker Of DNA Damage: Scientists have uncovered a marker of DNA d... http://t.co/yKYetjXu
BMC Gastroenterology | Abstract | Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas
biomedcentral.com — “Lymphadenectomy is performed to assess patient prognosis and to prevent metastasizing. Recently, it was questioned whether lymph node metastases were capable of metastasizing and therefore, if lymphadenectomy was still adequate. We evaluated whether the nodal status impacts on the occurrence of distant metastases by analyzing a highly selected cohort of colon cancer patients.” View full resource at biomedcentral.com
Most Recently Shared on March 24, 2012 at 10:46 am By:
Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinoma... http://t.co/ue5x1Kck
Journal of Experimental & Clinical Cancer Research | Abstract | Combined analysis of mRNA expression of ERCC1, BAG-1, BRCA1, RRM1 and TUBB3 to predict prognosis in patients with non-small cell lung cancer who received adjuvant chemotherapy
jeccr.com — “The aim of this study was to investigate prognostic value of excision repair cross-complementing 1 (ERCC1), BCL2-associated athanogene (BAG-1), the breast and ovarian cancer susceptibility gene 1 (BRCA1), ribonucleotide reductase subunit M1 (RRM1) and class III beta-tubulin (TUBB3) in patients with non-small cell lung cancer (NSCLC) who received platinum- based adjuvant chemotherapy.” View full resource at jeccr.com
Most Recently Shared on March 24, 2012 at 6:54 am By:
Combined analysis of mRNA expression of ERCC1, BAG-1, BRCA1, RRM1 and TUBB3 to predict prognosis in patients wit... http://t.co/ca7tVoLB
Pediatric Cancer, Volume 2
springer.com — “Pediatric Cancer: Teratoid/Rhabdoid, Brain Tumors, and Glioma · Epilepsy prognosis and treatment· Symptoms of tumors in children · Diagnostic imaging technology This se” View full resource at springer.com
Most Recently Shared on March 24, 2012 at 4:43 am By:
Pediatric Cancer, Volume 2: Teratoid/Rhabdoid, Brain Tumors, and Gliomaseries:Pediatric CancerPediatric Cancer: ... http://t.co/qorQfjni
Genes Hold Key in Breast Cancer Drug's Success (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- An increased number of chromosomes with a specific type of abnormality that prevents cancer cells from repairing their DNA may prove useful in predicting the response to cisplatin in breast cancer, researchers reported.” View full resource at qualitypointtech.net
Most Recently Shared on March 23, 2012 at 11:45 pm By:
Genes Hold Key in Breast Cancer Drug's Success (CME/CE): (MedPage Today) -- An increased number of chromosomes wi... http://t.co/3q1PfQ79
Advertisement
